Dark papillary muscles sign in a patient with arrhythmogenic mitral valve prolapse: a case report

Introduction. Recently, a subgroup of patients with mitral valve prolapse has been identified with an increased risk of ventricular arrhythmias and sudden cardiac death. One of the most characteristic signs of the arrhythmogenic mitral valve prolapse is mitral annular disjunction, detected by transthoracic or transesophageal echocardiography or by cardiac magnetic resonance imaging. Clinical and imaging data are used to stratify the risk of ventricular arrhythmias and determine patient management strategy.

Case report. The article presents a case of a young man with arrhythmogenic mitral valve prolapse. The case demonstrates the anatomical features of mitral valve and related subvalvular structures, and also considers their impact on cardiac arrhythmias. Particular attention is paid to the description of mitral annular disjunction and dark papillary muscles sign.

Conclusion. One of the tasks for imaging diagnostics in patients with ventricular arrhythmias and mitral valve prolapse is the assessment of phenotypic risk factors. Given the relationship of mitral annular disjunction with mitral valve prolapse, the development of mitral insufficiency and association with life-threatening ventricular arrhythmias, its timely diagnosis and follow-up of patients are extremely important.

1. Sabbag A, Essayagh B, Barrera JDR, et al. EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed by the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. Europace. 2022;24(12):1981-2003. doi:10.1093/europace/euac125.

2. Recommendations for quantitative assessment of the structure and function of the heart chambers. Russian Journal of Cardiology. 2012;(4s4):1-27. (In Russ.).

3. Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, et al. Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson. 2015;17(1):29. doi:10.1186/s12968-015-0111-7.

4. Perazzolo Marra M, Basso C, De Lazzari M, et al. Morphofunctional Abnormalities of Mitral Annulus and Arrhythmic Mitral Valve Prolapse. Circ Cardiovasc Imaging. 2016; 9(8):e005030. doi:10.1161/CIRCIMAGING.116.005030.

5. Basso C, Perazzolo Marra M, Rizzo S, et al. Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death. Circulation. 2015;132(7):556-66. doi:10.1161/CIRCULATIONAHA.115.016291.

6. Kitkungvan D, Nabi F, Kim RJ, et al. Myocardial Fibrosis in Patients with Primary Mitral Regurgitation with and Without Prolapse. J Am Coll Cardiol. 2018;72(8):823-34. doi:10.1016/j.jacc.2018.06.048.

7. Chakrabarti AK, Bogun F, Liang JJ. Arrhythmic Mitral Valve Prolapse and Mitral Annular Disjunction: Clinical Features, Pathophysiology, Risk Stratification, and Management. J Cardiovasc Dev Dis. 2022;9(2):61. doi:10.3390/jcdd9020061.

8. Aquaro GD, De Gori C, Grilli G, et al. Dark papillary muscles sign: a novel prognostic marker for cardiac magnetic resonance. Eur Radiol. 2023;33(7):4621-36. doi:10.1007/s00330-023-09400-x.

9. Scatteia A, Pascale CE, Gallo P, et al. Abnormal Papillary Muscle Signal on Cine MRI As a Typical Feature of Mitral Valve Prolapse. Sci Rep. 2020;10(1):9166. doi:10.1038/s41598-020-65983-1.

10. Rahimi K, Mohseni H, Otto CM, et al. Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults. PLoS Med. 2017;14(10):e1002404. doi:10.1371/journal.pmed.1002404.